Researchers describe the symptom profiles of respiratory viral infections.
Charles River to close ‘15 smaller sites’ as demand for early research declines
In another sign that biopharma companies are slowing their early R&D efforts, Charles River Laboratories is shuttering more than a dozen sites. The service provider